Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

ANGPTL4 E40K and T266M: effects on plasma triglyceride and HDL levels, postprandial responses, and CHD risk.

Arteriosclerosis, thrombosis, and vascular biology - 1 Dec 2008

Talmud Philippa J, Smart Melissa, Presswood Edward, Cooper Jackie A, Nicaud Viviane, Drenos Fotios, Palmen Jutta, Marmot Michael G, Boekholdt S Matthijs, Wareham Nicholas J, Khaw Kay-Tee, Kumari Meena, Humphries Steve E

Abstract excerpt

BACKGROUND: Angiopoietin-like 4 is a dual-function protein: an inhibitor of LPL, influencing plasma triglycerides (TGs), with angiogenic properties. We examined the association of common ANGPTL4 variants with CHD traits and risk in 5 studies (13,527 individuals). METHODS AND RESULTS: The effects...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Angiopoietins
Share to Cohort Studies

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Coronary Disease

Share to Heterozygote

Share to Homozygote

Share to Lipoproteins, HDL

Share to Postprandial Period

Share to Triglycerides

Source

Identifiers

PMID: 18974381
DOI: 10.1161/ATVBAHA.108.176917

Genes

ANGPTL4
MAF
LPL

Variants

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-18974381-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

ANGPTL4 E40K and T266M: effects on plasma triglyceride and HDL levels, postprandial responses, and CHD risk.PMID 18974381Read ↗

Impact of loss-of-function in angiopoietin-like 4 on the human phenome.Semantic proximity Read ↗

ANGPTL4 variants E40K and T266M are associated with lower fasting triglyceride levels in Non-Hispanic White Americans from the Look AHEAD Clinical Trial.Semantic proximity Read ↗

Impact of loss-of-function in angiopoietin-like 4 on the human phenomeSemantic proximity Read ↗

ANGPTL4 variants E40K and T266M are associated with lower fasting triglyceride levels and predicts cardiovascular disease risk in Type 2 diabetic Tunisian population.Semantic proximity Read ↗

The relationship between plasma angiopoietin-like protein 4 levels, angiopoietin-like protein 4 genotype, and coronary heart disease risk.Semantic proximity Read ↗

Inactivating Variants in ANGPTL4 and Risk of Coronary Artery Disease.Semantic proximity Read ↗

ANGPTL4 gene E40K variation protects against obesity‐associated dyslipidemia in participants with obesitySemantic proximity Read ↗

ANGPTL8 protein-truncating variant associated with lower serum triglycerides and risk of coronary disease.Semantic proximity Read ↗

Genetic inactivation of ANGPTL4 improves glucose homeostasis and is associated with reduced risk of diabetes.Semantic proximity Read ↗

Impacts of angiopoietin-like proteins on lipoprotein metabolism and cardiovascular events.Semantic proximity Read ↗

<i>ANGPTL8</i> protein-truncating variant and the risk of coronary disease, type 2 diabetes and adverse effectsSemantic proximity Read ↗

Angiopoietin-like protein 4 significantly predicts future cardiovascular events in coronary patients.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.